Y

Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675

Watchlist Manager
Yantai Dongcheng Biochemicals Co Ltd
SZSE:002675
Watchlist
Price: 12.76 CNY -4.99% Market Closed
Market Cap: 10.5B CNY
Have any thoughts about
Yantai Dongcheng Biochemicals Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Yantai Dongcheng Biochemicals Co Ltd

Current Assets 2.7B
Cash & Short-Term Investments 956.9m
Receivables 998.4m
Other Current Assets 786.1m
Non-Current Assets 5.9B
Long-Term Investments 366.3m
PP&E 2.3B
Intangibles 3B
Other Non-Current Assets 201.9m
Current Liabilities 1.8B
Accounts Payable 169.4m
Accrued Liabilities 123.4m
Short-Term Debt 983m
Other Current Liabilities 520.3m
Non-Current Liabilities 2.4B
Long-Term Debt 278.3m
Other Non-Current Liabilities 2.2B

Balance Sheet
Yantai Dongcheng Biochemicals Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
161
320
810
378
912
825
714
736
927
608
Cash
0
0
0
0
0
0
0
736
927
608
Cash Equivalents
161
319
810
377
911
824
713
0
0
0
Short-Term Investments
0
0
0
0
0
222
118
129
87
40
Total Receivables
195
372
572
697
1 007
1 076
1 089
976
1 030
889
Accounts Receivables
173
359
529
638
939
987
975
859
860
770
Other Receivables
22
13
42
59
68
89
114
116
170
119
Inventory
292
353
426
575
604
888
974
953
1 078
904
Other Current Assets
154
224
133
433
346
68
51
106
70
37
Total Current Assets
802
1 269
1 941
2 082
2 869
3 078
2 945
2 900
3 193
2 478
PP&E Net
376
436
614
651
981
1 179
1 306
1 616
1 994
2 223
PP&E Gross
376
436
614
651
981
1 179
1 306
1 616
1 994
2 223
Accumulated Depreciation
89
132
201
247
334
410
492
576
683
803
Intangible Assets
76
108
162
206
243
255
279
309
322
425
Goodwill
125
709
1 473
1 429
2 698
2 567
2 600
2 373
2 330
2 544
Note Receivable
0
7
6
6
10
4
6
1
33
46
Long-Term Investments
10
10
51
866
82
124
125
243
191
213
Other Long-Term Assets
5
10
21
34
86
88
132
213
114
153
Other Assets
125
709
1 473
1 429
2 698
2 567
2 600
2 373
2 330
2 544
Total Assets
1 393
N/A
2 548
+83%
4 268
+68%
5 273
+24%
6 967
+32%
7 295
+5%
7 393
+1%
7 656
+4%
8 177
+7%
8 082
-1%
Liabilities
Accounts Payable
39
46
54
66
79
86
185
280
193
176
Accrued Liabilities
15
3
44
52
86
100
106
127
149
147
Short-Term Debt
111
152
689
539
633
1 052
997
1 086
1 544
1 085
Current Portion of Long-Term Debt
0
0
0
150
392
284
70
158
51
158
Other Current Liabilities
63
77
333
473
804
910
540
392
456
385
Total Current Liabilities
198
278
1 120
1 281
1 993
2 432
1 897
2 043
2 393
1 952
Long-Term Debt
0
0
0
624
279
6
449
523
240
260
Deferred Income Tax
1
1
12
12
20
19
19
17
19
18
Minority Interest
15
188
316
386
427
486
497
626
534
620
Other Liabilities
11
33
53
67
64
59
63
50
242
457
Total Liabilities
224
N/A
500
+123%
1 500
+200%
2 371
+58%
2 784
+17%
3 002
+8%
2 925
-3%
3 259
+11%
3 428
+5%
3 307
-4%
Equity
Common Stock
173
221
704
704
802
802
802
802
825
825
Retained Earnings
422
486
593
737
999
1 115
1 332
1 290
1 517
1 603
Additional Paid In Capital
574
1 341
1 465
1 461
2 348
2 322
2 321
2 317
2 402
2 341
Other Equity
0
0
6
1
35
53
13
12
5
7
Total Equity
1 169
N/A
2 048
+75%
2 768
+35%
2 903
+5%
4 184
+44%
4 293
+3%
4 468
+4%
4 397
-2%
4 749
+8%
4 775
+1%
Total Liabilities & Equity
1 393
N/A
2 548
+83%
4 268
+68%
5 273
+24%
6 967
+32%
7 295
+5%
7 393
+1%
7 656
+4%
8 177
+7%
8 082
-1%
Shares Outstanding
Common Shares Outstanding
518
662
704
704
802
802
802
802
825
825

See Also

Discover More